PedAM
Pediatric Disease Annotations & Medicines
| Disease | hyperandrogenism |
| Phenotype | C0032460|polycystic ovary syndrome |
| Sentences | 28 |
| PubMedID- 23450052 | Background: polycystic ovary syndrome (pcos) is associated with hyperandrogenism and insulin resistance. |
| PubMedID- 26327890 | The available research suggests that hyperandrogenism featuring women with polycystic ovary syndrome (pcos) during their reproductive life persists also after menopause. |
| PubMedID- 20378617 | Background: the present study was designed to evaluate whether the alteration of aquaporin-9 (aqp-9) expression in granulosa cells (gcs) of patients with polycystic ovary syndrome (pcos) was associated with the hyperandrogenism in follicular fluid (ff). |
| PubMedID- 26236094 | In healthy female rats, a model of polycystic ovary syndrome with ir and hyperandrogenism, is induced by h-dages. |
| PubMedID- 26491443 | Similarly both men and women could suffer from various forms of metabolic dysfunction and abnormalities due to androgen imbalance, including hypoandrogenism in aging men [187, 188] and hyperandrogenism in women with polycystic ovary syndrome (pcos) [187, 189]. |
| PubMedID- 21228310 | Small trials also suggest that metformin has a positive impact on insulin resistance and hyperandrogenism in patients with polycystic ovary syndrome (36,37) or precocious pubarche (38,39). |
| PubMedID- 23575700 | Introduction and hypothesis: hyperandrogenism in women with polycystic ovary syndrome (pcos) could increase muscle mass and thereby pelvic floor muscle (pfm) strength, reducing the risk of urinary incontinence (ui). |
| PubMedID- 24152688 | Context: statins have been shown to improve hyperandrogenism in women with polycystic ovary syndrome (pcos). |
| PubMedID- 23812344 | Background: polycystic ovary syndrome (pcos) is associated with hyperandrogenism and an increased risk of type 2 diabetes and cardiovascular disease. |
| PubMedID- 26295295 | Obesity, insulin resistance (ir), inflammation, and hyperandrogenism may lead to polycystic ovary syndrome (pcos) and hypertension. |
| PubMedID- 22651247 | The hyperandrogenism in women with polycystic ovary syndrome is frequently, but not consistently, associated with increased total and abdominal adiposity [40-42]. |
| PubMedID- 26491440 | The role of androgens in females is not well established, but many lines of evidence indicate that hyperandrogenism in women with polycystic ovary syndrome (pcos) increases risk of developing nafld. |
| PubMedID- 22421986 | Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome. |
| PubMedID- 21986157 | Hirsutism score and the severity of hyperandrogenism associated with polycystic ovary syndrome in the southeastern region of turkey. |
| PubMedID- 20146169 | polycystic ovary syndrome (pcos) is associated with hyperandrogenism, insulin resistance (ir), and chronic inflammation. |
| PubMedID- 26476820 | Due to the characteristics of hyperandrogenism in polycystic ovary syndrome (pcos), it is plausible that women with pcos may have increased pelvic floor muscle (pfm) thickness and neuromuscular activity levels compared with controls. |
| PubMedID- 25246891 | Correlation of biochemical markers and clinical signs of hyperandrogenism in women with polycystic ovary syndrome (pcos) and women with non-classic congenital adrenal hyperplasia (ncah). |
| PubMedID- 22522778 | Aim: we aimed to compare the effects of metformin and metformin-rosuvastatin combination therapies on hyperandrogenism in patients with polycystic ovary syndrome (pcos). |
| PubMedID- 22837189 | polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic pcos phenotypes and healthy controls, independent of obesity and insulin resistance. |
| PubMedID- 25675386 | Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood. |
| PubMedID- 23194004 | Effects of metformin on serum insulin and anti-mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome. |
| PubMedID- 20663984 | polycystic ovary syndrome (pcos) is associated with hyperandrogenism and insulin resistance, possibly reflecting defects in skeletal muscle and adipocyte insulin signaling. |
| PubMedID- 22086521 | Objectives: the pelvic floor muscles are sensitive to androgens, and due to hyperandrogenism, women with polycystic ovary syndrome can have increased mass in these muscles compared to controls. |
| PubMedID- 26034121 | Hirsutism induced by hyperandrogenism can be associated with polycystic ovary syndrome, 21-hydroxylase (oh) deficiency or androgen-secreting tumors, including ovarian and adrenal tumors. |
| PubMedID- 20036327 | Insulin and hyperandrogenism in women with polycystic ovary syndrome. |
| PubMedID- 21177795 | hyperandrogenism in women with polycystic ovary syndrome persists after menopause. |
| PubMedID- 21622477 | Single nucleotide polymorphisms (snps) in hsd11b1, the gene encoding 11beta-hsd1, have been associated with type 2 diabetes and hypertension in population-based cohort studies, and with hyperandrogenism in patients with the polycystic ovary syndrome (pcos). |
| PubMedID- 25591557 | Identification of differentially expressed micrornas in the ovary of polycystic ovary syndrome with hyperandrogenism and insulin resistance. |
Page: 1